VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $572,000 | -43.0% | 5,650 | 0.0% | 0.00% | -66.7% |
Q3 2015 | $1,004,000 | -20.3% | 5,650 | -0.4% | 0.00% | 0.0% |
Q2 2015 | $1,259,000 | +30.5% | 5,675 | +16.2% | 0.00% | +50.0% |
Q1 2015 | $965,000 | +73.9% | 4,885 | +26.3% | 0.00% | +100.0% |
Q4 2014 | $555,000 | +45.7% | 3,868 | +33.4% | 0.00% | 0.0% |
Q3 2014 | $381,000 | -17.2% | 2,899 | -20.1% | 0.00% | 0.0% |
Q2 2014 | $460,000 | -40.6% | 3,629 | -38.3% | 0.00% | -50.0% |
Q1 2014 | $775,000 | +25.8% | 5,885 | +12.1% | 0.00% | +100.0% |
Q4 2013 | $616,000 | +36.9% | 5,249 | +21.8% | 0.00% | 0.0% |
Q3 2013 | $450,000 | -11.8% | 4,309 | -27.4% | 0.00% | 0.0% |
Q2 2013 | $510,000 | – | 5,935 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |